Table 7.
A. | |||||
---|---|---|---|---|---|
[VEGF121] (nM) |
to (s) Fixed |
Req ± SE (RU) |
kd ± SE (s−1) |
Red. X2 |
Adj. R2 |
100 | 174.6 | 30.1 ± 0.4 | 8.8 ± 0.2 × 10 −3 | 6.12 | 0.86 |
50 | 26.2 ± 0.4 | ||||
25 | 22.8 ± 0.4 | ||||
12.5 | 19.0 ± 0.4 | ||||
6.25 | 15.6 ± 0.4 |
B. | ||||||
---|---|---|---|---|---|---|
[VEGF121] (M) Fixed |
ka ± SE (M−1s−1) |
Rmax ± SE (RU) |
kd – Fixed (s−1) |
Red. X2 |
Adj. R2 |
KD ± SE (nM) |
1.00 × 10−7 | 1.43 ± 0.03 × 106 | 42.6 ± 0.2 | 8.8 × 10 −3 | 11.1 | 0.90 | 6.2 ± 0.2 |
5.00 × 10−8 | ||||||
2.50 × 10−8 | ||||||
1.25 × 10−8 | ||||||
6.25 × 10−9 |
A. Dissociation phase analysis of VEGF121 from VEGFR-1. Parameters obtained from global curve fitting (red lines Figure 6A) of dissociation data from VEGFR-1 (Equation 3). B. Association phase analysis of VEGF121 binding to VEGFR-1. Parameters from global fitting of association phase data to equation 2 (red lines Figure 6A) and calculated affinity (KD = kd / ka).